ArticleDiabetes, obesity & metabolism2020

Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care.

Samantha Wilkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.